Cardiac Troponinfor Earlier Diagnosis of Myocardial Infarctions

Time is Muscle – Earlier MI Diagnosis with High-sensitivity Troponin Assays
The detection of a rise and/or fall of cardiac troponin (cTn) plays a key role in the earlier diagnosis of myocardial infarction (MI). Cardiac troponins are markers of myocardial necrosis, and, because of their high cardiac-specificity, are the preferred biomarker for the diagnosis of MI.

Reliable Answers for Critical Needs
As a recognized worldwide leader in CVD testing, Siemens Healthineers High-Sensitivity Troponin I assays provide the clinical sensitivity and precision needed for earlier detection of necrosis and MI versus less-precise assays.

High-sensitivity troponin I is helping emergency departments efficiently triage patients who need immediate care, and quickly determine which patients can be discharged

The role of Cardiac Troponin in Myocardial Infarction Diagnosis

Dr. Peacock describes the science behind diagnosing a heart attack. Learn about the methods used to measure cardiac troponin, a protein released into the bloodstream during a heart attack, and the benefits of sensitive new technologies for earlier detection in the emergency department.

Cardiac troponin is a marker of cardiac injury, enabling clinicians to aid the diagnosis of myocardial infarction. Dr. Apple describes how new IFCC recommendations and guidelines for implementing high-sensitivity cardiac troponin assays will improve cardiac triage and patient outcomes, worldwide.

Involved in some of the most pioneering research for cardiovascular disease diagnostics, with an interest in the field of biochemical markers, Dr. Alan Wu is excited about the future of high-sensitivity troponin assays. In this video, Wu discusses how to validate this assay in your lab, and how this novel approach to cardiac triage management is potentially paradigm-changing, for both patients and hospitals.

High Sensitivity Troponin I Infographic